skip to Main Content

Request More Information

Cord Blood Uses In The United States

Cord Blood Uses in the United States

 

Cord blood is sourced from the blood vessels of the umbilical cord. After a baby is born and the umbilical cord is cut, the cord blood can be collected and preserved. In the United States, cord blood banking is slowly becoming a popular topic among soon-to-be parents. With the birth of their baby, parents get to decide if they want to privately bank, donate or discard their child’s cord blood.

 

Cord blood banking:

Cord blood banks can be either private or public. With private banks, parents pay to have their baby’s cord blood stored. The stored cord blood may be used for the baby directly or for the baby’s first or second-degree relatives. First-degree relatives include parents, siblings, and children. Second-degree relatives include grandparents, grandchildren, uncles, aunts, nephews, nieces, and half-siblings.

 

Parents may also choose to donate the cord blood to a public bank for an unrelated person to use. Donated cord blood can be used for sick patients who are in need of hematopoietic stem cell transplant. Unrelated patients are matched to a donated cord blood unit based on human leukocyte antigen types (similar to matching patients based on blood type).  

 

FDA approved cord blood uses:

The only FDA approved uses for hematopoietic stem cell transplants using cord blood are for disorders that relate directly to the hematopoietic or blood-forming system. Some cancers, blood disorders, bone marrow failure syndromes, metabolic disorders, and immunodeficiencies fall into the category related to the blood-forming system.

 

No other diseases may be treated in the United States with cord blood despite scientific studies suggesting its remarkable applications for other conditions.

 

Cord blood, stroke, and the FDA:

Using cord blood to treat ischemic stroke is not yet FDA approved despite studies suggesting its groundbreaking potential. In a recent study conducted at Duke University, all stroke survivors treated with cord blood within 10 days had improvements within three months. While the FDA is slow to approve innovative treatments in the US, cord blood treatments for stroke survivors are readily available in Germany.

 

If you or a loved one have recently suffered from an ischemic stroke, consider cord blood treatments in Munich, Germany. Germany’s healthcare system is ranked No. 11 in the world while the United States is ranked No. 30. That means you can expect advanced treatment practices, top-rated healthcare facilities, and extremely professional staff.

 

Get more information on CBC Health’s ischemic stroke treatment by calling (855) 426-4623.

 

Sources:

https://stemcellsjournals.onlinelibrary.wiley.com/doi/full/10.1002/sctm.18-0008 (Duke Study)

Back To Top